Blog
Patient Resources
Explore our latest articles and patient resources from Sacramento NeuroPsych Associates, where our experts share insights on mental health, depression, anxiety disorders, PTSD, and OCD. Learn about advanced, FDA-approved treatments such as TMS (Transcranial Magnetic Stimulation) and Spravato® (esketamine), a ketamine nasal spray offering rapid-onset treatment for depression. Discover how our neuroscience and psychology specialists use intranasal ketamine treatment and other evidence-based therapies to enhance your well-being.
How Fast Does Spravato Work? Timeline, Results, and What to Expect
For individuals living with treatment-resistant depression (TRD), one of the most common questions about Spravato® (esketamine) is how quickly it works
February 18, 2026
January 26, 2026
Understand T.O.V.A. test score ranges, what counts as normal, and how results are interpreted in ADHD and attention disorder evaluations.
January 22, 2026
TMS therapy has become a leading option for treatment-resistant depression—explore the evidence behind its success rates, effectiveness, and lasting results.
December 17, 2025
The Test of Variables of Attention (T.O.V.A.) is one of the most widely used objective tools for assessing attention and impulsivity. For many patients...
November 19, 2025
Knowing a therapy is FDA-approved gives you confidence in its safety, oversight, and evidence base
October 29, 2025
Ketamine nasal spray (specifically its derivative esketamine) is an FDA-approved treatment for treatment-resistant depression (TRD).
October 5, 2023
Are you or a loved one considering TMS therapy to conquer the shadows of depression and other mental health challenges?
September 8, 2023
Depression is a prevalent mental health condition that affects a large number of individuals worldwide.
August 7, 2023
When you hear the term ‘brain stimulation’, what initially comes to mind?
July 11, 2023
Depression is affecting an ever-increasing number of Americans, as reported by ongoing surveys and research.
June 27, 2023
On the internet, there are numerous therapies-related myths.
May 24, 2023
The Anxiety & Depression Association of America reported that depression is the foremost reason of disability among U.S. people aged below 44 years.
May 15, 2023
Transcranial Magnetic Stimulation, or TMS, can initially appear intimidating.